750 followers
RT @FrontCVMedicine: New Research: Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mic…
RT @FrontCVMedicine: New Research: Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mic…
RT @FrontCVMedicine: New Research: Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mic…
New Research: Empagliflozin inhibits coronary microvascular dysfunction and reduces cardiac pericyte loss in db/db mice: Background Coronary microvascular dysfunction (CMD) is a pathophysiological feature of diabetic heart disease.… https://t.co/mhNK1aBdO